- Recent Funding
- Investors
- AbbVie
AbbVie portfolio
AbbVie has 8 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Cloverleaf Bio's $33M Seed round in September 2026, alongside 4BIO Capital, BrightEdge - American Cancer Society, Eli Lilly and 3 others. By category, its portfolio leans toward Health and bio (7) and Education (1). It has co-invested with Polaris, Vida Ventures and Avalon Ventures, most often Polaris (4 rounds).
What AbbVie invests in
- Health and bio · 7 · 88%
- Education · 1 · 13%
- Commerce and retail · 1 · 13%
- Consumer and social · 1 · 13%
AbbVie recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Seed · $33M | 4BIO Capital (lead), BrightEdge - American Cancer Society, Eli Lilly +3 | ||
| Series A · $200M | ARCH Venture Partners, Leaps by Bayer, Vida Ventures +4 | ||
| Series B+ | Vida Ventures, Longitude Capital, Surveyor Capital +5 | ||
| Series B+ · $107M | Avalon Ventures, Pfizer Venture Investments, Polaris +3 | ||
| Series B+ · $60M | Vida Ventures (lead), Longitude Capital, Surveyor Capital (lead) +3 | ||
| Series B+ · $50M | Avalon Ventures, Pfizer Venture Investments, Polaris +2 | ||
| Seed · $4M | XFactor Ventures, Ishi Solar, Haystack +6 | ||
| Series B+ · $63M | EcoR1 Capital (lead), Droia Ventures, The Mark Foundation for Cancer Research +4 |
How AbbVie invests
AbbVie portfolio companies
CCloverleaf Bio$33MSeed · Sep 2026
SSoufflé Therapeutics$200MSeries A · Oct 2025
QQuanta TherapeuticsSeries B+ · Jun 2023
JJnana Therapeutics$107MSeries B+ · Nov 2022
SStarday$4MSeed · Aug 2021
AAccent Therapeutics$63MSeries B+ · Apr 2020
ZZag Biobacker
TThird Arc Biobacker
| Company | Round with AbbVie | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Seed · $33M | $33M | Sep 8, 2026 Seed |
Health and bio |
Series A · $200M | $335M | Oct 13, 2026 Series B+ |
Health and bio |
Series B+ | $60M | Oct 24, 2026 Series B+ |
Health and bio |
Series B+ · $107M | $207M | Nov 15, 2022 Series B+ |
Commerce and retail |
Seed · $4M | $15M | Apr 8, 2025 Series A |
Health and bio |
Series B+ · $63M | $178M | Jan 23, 2024 Series B+ |
Health and bio |
backer | undisclosed | — |
Health and bio |
backer | $217M | Feb 4, 2026 Series A |
Most frequent co-investors
PPolaris4 shared rounds · last Oct 13, 2025
VVida Ventures3 shared rounds · last Oct 13, 2025
AAvalon Ventures3 shared rounds · last Nov 15, 2022
VVersant Ventures3 shared rounds · last Nov 15, 2022
BBiotechnology Value Fund2 shared rounds · last Jun 9, 2023
SSofinnova Partners2 shared rounds · last Jun 9, 2023
LLongitude Capital2 shared rounds · last Jun 9, 2023
SSurveyor Capital2 shared rounds · last Jun 9, 2023
RRA Capital Management2 shared rounds · last Nov 15, 2022
PPfizer Venture Investments2 shared rounds · last Nov 15, 2022
DDraper Associates1 shared round · last Sep 8, 2026
EEli Lilly1 shared round · last Sep 8, 2026
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
KKorea Credit Guarantee Fund8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TThe Column Group8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
AAsabys Partners8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 9 rounds on Recent Funding that name AbbVie. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists AbbVie, which is a subset of its real portfolio. API: /api/v1/investors/abbvie (get a free API key). More: the most active VC firms and new venture capital funds.